SE7706203L - CANCER DETERMINATION PROCEDURE - Google Patents
CANCER DETERMINATION PROCEDUREInfo
- Publication number
- SE7706203L SE7706203L SE7706203A SE7706203A SE7706203L SE 7706203 L SE7706203 L SE 7706203L SE 7706203 A SE7706203 A SE 7706203A SE 7706203 A SE7706203 A SE 7706203A SE 7706203 L SE7706203 L SE 7706203L
- Authority
- SE
- Sweden
- Prior art keywords
- cancer
- tubes
- detected
- tumour
- extracts
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1520208 Detection of cancer F HOFFMANNLA ROCHE & CO A G 26 May 1977 [27 May 1976] 22283/77 Heading G1B Melanoma, bladder carcinoma, ovarian cancer, lung cancer, liver cancer, cervical cancer or sarcoma in humans are detected by a method comprising incubating a measured amount of patient leukocytes with aqueous basic extracts of the tumour of the cancer to be detected then determining the "leukocyte non-adherence index" (defined) by comparison with a control, for example by carrying out the incubation in glass tubes placed in a horizontal position then placing the tubes vertically and counting the number of cells not adhering to the walls of the tubes using a leucocytometer, the presence of a particular form of cancer being indicated when there is the greatest number of non-adherent cells. The tumour extracts may be diluted for use using "Medium 199" which is a (defined) composition containing amino acids, vitamins, inorganic salts and other components.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69045476A | 1976-05-27 | 1976-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7706203L true SE7706203L (en) | 1977-11-28 |
Family
ID=24772522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7706203A SE7706203L (en) | 1976-05-27 | 1977-05-26 | CANCER DETERMINATION PROCEDURE |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS52145517A (en) |
| AT (1) | AT357690B (en) |
| AU (1) | AU506539B2 (en) |
| BE (1) | BE855063A (en) |
| DE (1) | DE2724114A1 (en) |
| DK (1) | DK233277A (en) |
| ES (1) | ES459164A1 (en) |
| FI (1) | FI771646A7 (en) |
| FR (1) | FR2352533A1 (en) |
| GB (1) | GB1520208A (en) |
| IE (1) | IE45284B1 (en) |
| IL (1) | IL52133A0 (en) |
| LU (1) | LU77413A1 (en) |
| NL (1) | NL7705873A (en) |
| NO (1) | NO771860L (en) |
| NZ (1) | NZ184159A (en) |
| SE (1) | SE7706203L (en) |
| ZA (1) | ZA773026B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3999944A (en) * | 1975-02-28 | 1976-12-28 | Hoffmann-La Roche Inc. | Detection of breast cancer |
| US4043757A (en) * | 1975-05-20 | 1977-08-23 | Ortho Pharmaceutical Corporation | Method for detection of human mammary carcinoma |
-
1977
- 1977-05-20 NZ NZ184159A patent/NZ184159A/en unknown
- 1977-05-20 AU AU25341/77A patent/AU506539B2/en not_active Expired
- 1977-05-20 ZA ZA00773026A patent/ZA773026B/en unknown
- 1977-05-20 IL IL52133A patent/IL52133A0/en unknown
- 1977-05-24 IE IE1055/77A patent/IE45284B1/en unknown
- 1977-05-24 FI FI771646A patent/FI771646A7/fi not_active Application Discontinuation
- 1977-05-25 LU LU77413A patent/LU77413A1/xx unknown
- 1977-05-25 JP JP6000577A patent/JPS52145517A/en active Pending
- 1977-05-25 FR FR7715965A patent/FR2352533A1/en active Granted
- 1977-05-26 AT AT376977A patent/AT357690B/en not_active IP Right Cessation
- 1977-05-26 SE SE7706203A patent/SE7706203L/en not_active Application Discontinuation
- 1977-05-26 DK DK233277A patent/DK233277A/en not_active Application Discontinuation
- 1977-05-26 NO NO771860A patent/NO771860L/en unknown
- 1977-05-26 GB GB22283/77A patent/GB1520208A/en not_active Expired
- 1977-05-26 ES ES459164A patent/ES459164A1/en not_active Expired
- 1977-05-26 BE BE177925A patent/BE855063A/en unknown
- 1977-05-27 NL NL7705873A patent/NL7705873A/en not_active Application Discontinuation
- 1977-05-27 DE DE19772724114 patent/DE2724114A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ZA773026B (en) | 1978-04-26 |
| IE45284B1 (en) | 1982-07-28 |
| ATA376977A (en) | 1979-12-15 |
| NO771860L (en) | 1977-11-29 |
| BE855063A (en) | 1977-11-28 |
| DE2724114A1 (en) | 1977-12-15 |
| AU2534177A (en) | 1978-11-23 |
| LU77413A1 (en) | 1978-06-26 |
| NL7705873A (en) | 1977-11-29 |
| DK233277A (en) | 1977-11-28 |
| FR2352533A1 (en) | 1977-12-23 |
| AT357690B (en) | 1980-07-25 |
| JPS52145517A (en) | 1977-12-03 |
| IL52133A0 (en) | 1977-07-31 |
| FR2352533B1 (en) | 1980-06-13 |
| ES459164A1 (en) | 1978-04-16 |
| AU506539B2 (en) | 1980-01-10 |
| IE45284L (en) | 1977-11-27 |
| GB1520208A (en) | 1978-08-02 |
| NZ184159A (en) | 1979-03-28 |
| FI771646A7 (en) | 1977-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1358828A (en) | Process for detecting the presence of human carcinoembryonic antigen material or component a or b thereof in blood | |
| JPS51134558A (en) | Measuring unit | |
| GB1290642A (en) | ||
| GB1525143A (en) | Detection of fibrinolysis and/or blood coagulation | |
| SE8004542L (en) | DIAGNOSTIC TEST | |
| ATE11930T1 (en) | IN VITRO METHOD FOR DETERMINING CANCER IN MAMMALIAN TISSUE. | |
| IT1064135B (en) | PROCEDURE AND MEANS OF CULTURE AND / OR MEASUREMENT OF MICROORGANISMS | |
| SE7706203L (en) | CANCER DETERMINATION PROCEDURE | |
| GB1164255A (en) | Improvements in or relating to Diagnostic Package. | |
| SE8201128L (en) | PROCEDURE FOR REPRODUCTION OF VIRULENT TREPONEMA PALLIDUM IN TISSUE ULTUR | |
| ES8402876A1 (en) | A method of determining dTk isoenzyme activity and the use thereof. | |
| JPS5342002A (en) | Method for inspection of magnetic recording medium | |
| Szmuc et al. | Synonymy of the ichnogenus Lingulichnites Szmuc, Osgood & Meinke, 1976, with Lingulichnus Hakes 1976 | |
| GB686289A (en) | Improvements in or relating to record cards, tapes or the like supports, and the recording of magnetic marks on such supports | |
| JPS5216995A (en) | Radar signal processor | |
| JPS5282156A (en) | Medium input test method | |
| JPS5238994A (en) | Biological sterilization checking reagent | |
| PETROSIAN | Differential games of pursuit(Russian book) | |
| JPS5425759A (en) | Coordinate reader of three-dimensional models | |
| GB1503851A (en) | Process for preparing cephalosporin | |
| SU694157A1 (en) | Laboratory incubator | |
| JPS56150356A (en) | Immunologic measuring method | |
| JPS5231777A (en) | S/n ratio measuring apparatus | |
| JPS5223983A (en) | Breakage detector | |
| JPS5430898A (en) | Currency transaction system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7706203-2 Format of ref document f/p: F |